Emmessar Biotech & Nutrition has informed that the Board of Directors at their meeting held today, has approved and took on record the Un-Audited Financial Results of the Company for the first quarter ended June 30, 2022. The company has enclosed a copy of the said Un-Audited Financial Results along with the Limited Review Report for the first quarter ended June 30, 2022. The results will also be filed in XBRL format. The Board meeting commenced at 12.30 pm and concluded at 1:30 pm.
The above information is a part of company’s filings submitted to BSE.
